Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms

Nina R. Schooler, Robert W. Buchanan, Thomas Laughren, Stefan Leucht, Henry A. Nasrallah, Steven G. Potkin, Danielle Abi-Saab, Carmen Galani Berardo, Dragana Bugarski-Kirola, Thomas Blaettler, Chris J. Edgar, Anna Lena Nordstroem, Cedric O'Gorman, George Garibaldi

Research output: Contribution to journal › Article › peer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Defining therapeutic benefit for people with schizophrenia: Focus on negative symptoms'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Medicine and Dentistry

Nursing and Health Professions

Neuroscience